Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet. 2004;364:937–52. https://doi.org/10.1016/S0140-6736(04)17018-9.
Article
Google Scholar
Liu K, Daviglus ML, Loria CM, et al. Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the Coronary Artery Risk Development in (Young) Adults (CARDIA) study. Circulation. 2012;125:996–1004. https://doi.org/10.1161/circulationaha.111.060681.
Article
PubMed
PubMed Central
Google Scholar
Cardiovascular diseases (CVDs), https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (2017, Accessed 20 Sept 2020).
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–81. https://doi.org/10.1093/eurheartj/ehw106.
Article
PubMed
PubMed Central
Google Scholar
Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. J Am Coll Cardiol. 2011;58:2432. https://doi.org/10.1016/j.jacc.2011.10.824.
Article
PubMed
Google Scholar
Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929–40. https://doi.org/10.1016/s0140-6736(09)60330-5.
Article
PubMed
Google Scholar
Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23:636–48. https://doi.org/10.1177/2047487315569401.
Article
PubMed
Google Scholar
Ferrari R, Ford I, Greenlaw N, et al. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry. Eur J Prev Cardiol. 2014;22:1056–65. https://doi.org/10.1177/2047487314547652.
Article
PubMed
Google Scholar
Cacoub PP, Zeymer U, Limbourg T, et al. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart. 2011;97:660. https://doi.org/10.1136/hrt.2010.213710.
Article
PubMed
Google Scholar
Støre Govatsmark RE, Krizak Halle K, Bendiktsen Berge V, et al. Årsrapport 2019., https://www.kvalitetsregistre.no/sites/default/files/2021-04/Årsrapport%202019%20Norsk%20hjerteinfarktregister.pdf (2020, Accessed 28 Feb 2021).
Fiane A, Bjørnstad J and O. G. Årsrapport for 2019 med
plan for forbedringstiltak., https://www.kvalitetsregistre.no/sites/default/files/2021-02/Årsrapport%202019%20Hjertekirurgi_0.pdf (2020, Accessed 28 Feb 2021).
Jortveit J, Halvorsen S, Kaldal A, et al. Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease. BMC Cardiovasc Disord. 2019;19:71. https://doi.org/10.1186/s12872-019-1062-y.
Article
PubMed
PubMed Central
Google Scholar
Sverre E, Peersen K, Husebye E, et al. Unfavourable risk factor control after coronary events in routine clinical practice. BMC Cardiovasc Disord. 2017;17:40. https://doi.org/10.1186/s12872-016-0387-z.
Article
PubMed
PubMed Central
Google Scholar
Jortveit J, Halvorsen S. Geographical differences in prescription of secondary preventive drug therapy after acute myocardial infarction in Norway. European Heart J Cardiovasc Pharmacother. 2017;3:132–3. https://doi.org/10.1093/ehjcvp/pvx008.
Article
Google Scholar
Olsen SJ, Schirmer H, Bønaa KH, et al. Cardiac rehabilitation after percutaneous coronary intervention: results from a nationwide survey. Eur J Cardiovasc Nurs. 2018;17:273–9. https://doi.org/10.1177/1474515117737766.
Article
PubMed
Google Scholar
Svilaas A, Ström EC, Svilaas T, et al. Reproducibility and validity of a short food questionnaire for the assessment of dietary habits. Nutr Metab Cardiovasc Dis. 2002;12:60–70.
CAS
PubMed
Google Scholar
Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375–414. https://doi.org/10.1093/eurheartj/ehm316.
Article
PubMed
Google Scholar
Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–701. https://doi.org/10.1093/eurheartj/ehs092.
Article
CAS
PubMed
Google Scholar
Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315. https://doi.org/10.1093/eurheartj/ehv320.
Article
CAS
PubMed
Google Scholar
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39:119–77. https://doi.org/10.1093/eurheartj/ehx393.
Article
Google Scholar
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019;41:111–88. https://doi.org/10.1093/eurheartj/ehz455.
Article
Google Scholar
Collet J-P, Thiele H, Barbato E, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2020. https://doi.org/10.1093/eurheartj/ehaa575.
Article
PubMed
PubMed Central
Google Scholar
Otterstad JE. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2003;10:429–37. https://doi.org/10.1097/01.hjr.0000107024.38316.6a.
Article
Google Scholar
Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD001800.pub2.
Article
PubMed
Google Scholar
Janssen V, De Gucht V, Dusseldorp E, et al. Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2013;20:620–40. https://doi.org/10.1177/2047487312462824.
Article
PubMed
Google Scholar
van Halewijn G, Deckers J, Tay HY, et al. Lessons from contemporary trials of cardiovascular prevention and rehabilitation: a systematic review and meta-analysis. Int J Cardiol. 2017;232:294–303. https://doi.org/10.1016/j.ijcard.2016.12.125.
Article
PubMed
Google Scholar
Johansson S, Rosengren A, Young K, et al. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2017;17:53–53. https://doi.org/10.1186/s12872-017-0482-9.
Article
PubMed
PubMed Central
Google Scholar
Sulo G, Vollset SE, Nygård O, et al. Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a Cardiovascular Disease in Norway Project). Am J Cardiol. 2014;113:1777–81. https://doi.org/10.1016/j.amjcard.2014.03.006.
Article
PubMed
Google Scholar
Riley H, Ainani N, Turk A, et al. Smoking cessation after hospitalization for myocardial infarction or cardiac surgery: assessing patient interest, confidence, and physician prescribing practices. Clin Cardiol. 2019;42:1189–94. https://doi.org/10.1002/clc.23272.
Article
PubMed
PubMed Central
Google Scholar
Boudreaux ED, Bock B, O’Hea E. When an event sparks behavior change: an introduction to the sentinel event method of dynamic model building and its application to emergency medicine. Acad Emerg Med. 2012;19:329–35. https://doi.org/10.1111/j.1553-2712.2012.01291.x.
Article
PubMed
PubMed Central
Google Scholar
Snaterse M, Scholte Op Reimer WJ, Dobber J, et al. Smoking cessation after an acute coronary syndrome: immediate quitters are successful quitters. Neth Heart J. 2015;23:600–7. https://doi.org/10.1007/s12471-015-0755-9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Voogdt-Pruis HR, Beusmans GH, Gorgels AP, et al. Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial. Br J Gen Pract. 2010;60:40–6. https://doi.org/10.3399/bjgp10X482095.
Article
PubMed
PubMed Central
Google Scholar
Giannuzzi P, Temporelli PL, Marchioli R, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the italian cardiac rehabilitation network. Arch Intern Med. 2008;168:2194–204. https://doi.org/10.1001/archinte.168.20.2194.
Article
PubMed
Google Scholar
Peersen K, Munkhaugen J, Gullestad L, et al. The role of cardiac rehabilitation in secondary prevention after coronary events. Eur J Prev Cardiol. 2017;24:1360–8. https://doi.org/10.1177/2047487317719355.
Article
PubMed
Google Scholar
Dibao-Dina C, Angoulvant D, Lebeau JP, et al. Patients’ adherence to optimal therapeutic, lifestyle and risk factors recommendations after myocardial infarction: Six years follow-up in primary care. PLoS ONE. 2018;13:e020986. https://doi.org/10.1371/journal.pone.0202986.
Article
CAS
Google Scholar
Hald K, Larsen FB, Nielsen KM, et al. Medication adherence, biological and lifestyle risk factors in patients with myocardial infarction: a ten-year follow-up on socially differentiated cardiac rehabilitation. Scand J Prim Health Care. 2019;37:182–90. https://doi.org/10.1080/02813432.2019.1608046.
Article
PubMed
PubMed Central
Google Scholar
Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713–22. https://doi.org/10.1056/NEJMoa1615664.
Article
CAS
PubMed
Google Scholar
Kereiakes DJ, Robinson JG, Cannon CP, et al. Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study. Am Heart J. 2015;169:906–15. https://doi.org/10.1016/j.ahj.2015.03.004.
Article
CAS
PubMed
Google Scholar
Gragnano F, Natale F, Concilio C, et al. Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience. J Cardiovasc Med. 2018;19:75–7. https://doi.org/10.2459/jcm.0000000000000611.
Article
Google Scholar
Cesaro A, Gragnano F, Fimiani F, et al. Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk. Eur J Prev Cardiol. 2020;27:556–8. https://doi.org/10.1177/2047487319839179.
Article
PubMed
Google Scholar
Anderson JW, Konz EC, Frederich RC, et al. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74:579–84. https://doi.org/10.1093/ajcn/74.5.579.
Article
CAS
PubMed
Google Scholar
Valgimigli M, Gragnano F, Branca M, et al. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. BMJ. 2021;373:1332. https://doi.org/10.1136/bmj.n1332.
Article
Google Scholar